No, you should not stop a prescribed acid-suppressing medicine simply to try betaine HCl or another hydrochloric-acid supplement. Proton pump inhibitors (PPIs) and H2 blockers may be protecting the esophagus or stomach from acid-related injury, and stopping them without reviewing the original diagnosis can allow symptoms or underlying damage to return. Long-term PPI use can also be followed by temporary rebound acid symptoms when treatment is discontinued. If you suspect low stomach acid or want to consider HCl supplementation, discuss your medication, digestive history and treatment goals with a qualified healthcare professional before making changes.

Stomach acid is essential to normal digestion. It helps prepare dietary proteins for breakdown, activates the enzyme pepsin, contributes to the release of certain nutrients from food and provides a protective barrier against many swallowed microorganisms.

Because acid-suppressing medicines reduce this normal gastric acidity, some people wonder whether they should discontinue their medication and replace it with supplemental hydrochloric acid.

That question is understandable, particularly when digestive symptoms such as bloating, heaviness after meals or poor food tolerance continue despite treatment.

However, reducing stomach acid and adding stomach acid serve different purposes, and neither approach is appropriate for everyone.

Acid-suppressing medicines can protect tissues from injury. Betaine HCl, by contrast, temporarily increases acidity but has not been established as a treatment for GERD or as a replacement for prescribed acid suppression.

The important question is therefore not simply whether stomach acid is beneficial.

It is why acid suppression was prescribed, whether that treatment is still necessary and whether additional gastric acidity would be appropriate or potentially harmful.

Why Are Acid-Suppressing Medicines Prescribed?

Acid-suppressing medicines reduce the amount of hydrochloric acid produced by the stomach.

Although gastric acid is necessary for normal digestion, it can contribute to tissue injury when it repeatedly reaches areas that are not adequately protected.

The esophagus is a particularly important example.

Acid reflux occurs when stomach contents move backward into the esophagus. Repeated acid exposure can cause heartburn, inflammation and, in some individuals, erosive esophagitis.

Reducing gastric acidity can make refluxed material less irritating and allow damaged tissue to heal.

Acid suppression is also used in several other medical situations.

Gastroesophageal Reflux Disease

Gastroesophageal reflux disease, or GERD, occurs when reflux produces troublesome symptoms or complications.

PPIs are effective treatments because they substantially reduce acid exposure in the esophagus.

They do not necessarily prevent every reflux event, but they can reduce acid-related symptoms and injury.

Erosive Esophagitis

Repeated exposure to gastric acid can damage the esophageal lining.

When erosive esophagitis is present, acid suppression helps the injured tissue heal.

People with severe erosive esophagitis may require ongoing treatment because the condition can recur when acid suppression is withdrawn.

Peptic Ulcers

Peptic ulcers can develop in the stomach or duodenum, commonly in association with Helicobacter pylori infection or nonsteroidal anti-inflammatory drugs.

Reducing acid exposure can promote ulcer healing.

If H. pylori infection is present, additional treatment is usually required to eradicate the infection.

Prevention of Gastrointestinal Bleeding

Some individuals have an elevated risk of upper gastrointestinal bleeding because of previous ulcers or medications that increase bleeding risk.

In selected patients, acid suppression helps reduce the risk of serious gastrointestinal complications.

Other Conditions Requiring Long-Term Treatment

Conditions such as Barrett's esophagus, severe recurrent reflux-related injury and certain acid-hypersecretion disorders may justify continued therapy.

The duration and intensity of treatment depend on the diagnosis.

When a medicine is protecting damaged or vulnerable tissue, stopping it simply to increase stomach acidity may remove an important safeguard.

What Is the Difference Between PPIs, H2 Blockers and Betaine HCl?

These products affect gastric acidity through different mechanisms.

Proton Pump Inhibitors

Proton pump inhibitors reduce acid secretion by inhibiting the gastric proton pumps responsible for the final stage of hydrochloric-acid production.

Common examples include:

• Omeprazole
• Esomeprazole
• Pantoprazole
• Lansoprazole
• Rabeprazole
• Dexlansoprazole

PPIs provide substantial acid suppression and are commonly used for GERD, erosive esophagitis and peptic ulcer disease.

H2 Receptor Blockers

H2 blockers reduce acid secretion by blocking histamine signaling involved in stimulating the stomach's acid-producing cells.

Famotidine is a commonly used example.

H2 blockers are generally less potent than PPIs for healing erosive esophagitis, although they can be useful in selected situations.

Betaine Hydrochloride

Betaine hydrochloride, commonly called betaine HCl, is a supplemental source of hydrochloric acid.

Unlike PPIs and H2 blockers, which reduce acid production, betaine HCl can temporarily increase acidity within the stomach.

Its physiological action is therefore different from that of acid-suppressing medication.

However, increasing acidity does not automatically improve reflux, indigestion or nutrient absorption.

Those outcomes depend on the underlying condition and have not been established as general benefits of betaine HCl supplementation.

Can You Take Betaine HCl While Taking Omeprazole or Another PPI?

Do not combine betaine HCl with omeprazole, pantoprazole or another prescribed PPI without specific medical guidance. The products have opposing effects on stomach acidity, and adding acid may undermine the intended treatment goal or cause irritation in someone with an acid-sensitive gastrointestinal condition.

PPIs are often prescribed because reducing acidity is necessary to control symptoms or allow tissue healing.

Betaine HCl increases gastric acidity temporarily.

Taking both together is not an established digestive-health strategy for routine clinical use.

It is important to distinguish this recommendation from a claim that combining the substances always produces a specific toxic drug interaction.

Research has deliberately studied betaine HCl in healthy volunteers whose gastric acidity was suppressed with a PPI.

Those experiments demonstrated temporary stomach re-acidification.

However, the studies were designed to investigate gastric pH and drug-absorption questions, not to establish the safety or effectiveness of using HCl to treat GERD or replace prescribed acid suppression.

A controlled research experiment in healthy volunteers should not be interpreted as a recommendation for self-treatment in people with reflux, ulcers or esophageal inflammation.

Why Might Stopping Acid-Suppressing Medicine Be Risky?

The main concern is not simply that heartburn may return.

It is that the condition being treated may still be present.

For example, someone with severe erosive esophagitis may experience a recurrence of acid-related tissue injury after stopping effective treatment.

A person with a history of bleeding ulcers may lose an important protective measure.

Someone with an ulcer that has not fully healed may also be vulnerable to further injury.

These risks depend on the person's diagnosis and clinical circumstances.

Not everyone taking a PPI requires lifelong therapy, but some people have clear reasons to continue treatment.

The American Gastroenterological Association recommends regularly reviewing the indication for PPI therapy while generally avoiding discontinuation in patients with complicated GERD or substantial gastrointestinal bleeding risk.

The decision to stop acid suppression should be based on whether the medicine remains medically indicated, not simply on a desire to restore normal stomach acidity.

What Is Rebound Acid Hypersecretion?

Rebound acid hypersecretion is a temporary increase in gastric acid secretion that can occur after prolonged acid-suppressing treatment is discontinued.

When PPIs substantially reduce gastric acidity, the body adapts through changes in the regulation of acid production.

One important response involves increased gastrin signaling.

Gastrin is a hormone involved in stimulating gastric acid secretion.

When PPI treatment is withdrawn, these regulatory changes may temporarily contribute to increased acid activity.

Some people consequently experience heartburn, acid regurgitation or upper abdominal discomfort after stopping treatment.

However, rebound symptoms are not inevitable.

The likelihood, duration and severity vary between individuals, and separating rebound symptoms from recurrence of the original condition can be difficult.

How Long Does Rebound Acid Last?

Rebound symptoms may emerge during the days or weeks following PPI discontinuation.

For some people, symptoms are temporary and improve as acid regulation readjusts.

Others experience persistent symptoms because their underlying reflux disease remains active.

There is no single timeline that applies to everyone.

Factors such as the duration of prior treatment, dose, underlying diagnosis and individual physiology can influence the experience.

If symptoms continue or become troublesome, further evaluation may be needed to determine whether they represent rebound acid activity, recurrent GERD or another condition.

Does Rebound Heartburn Prove That You Have Too Much Stomach Acid?

No. Symptoms following PPI withdrawal do not necessarily establish that a person has chronically excessive gastric acid production.

They may reflect a temporary physiological response, recurrence of reflux or increased esophageal sensitivity.

Likewise, they do not establish that the person previously had insufficient stomach acid and now requires hydrochloric-acid supplements.

The timing of symptoms provides useful information, but it is not a direct diagnostic measurement of gastric acidity.

Should PPIs Be Stopped Gradually or All at Once?

Both gradual dose reduction and direct discontinuation can be appropriate when a clinician determines that PPI deprescribing is suitable.

The American Gastroenterological Association states that either approach can be considered.

However, this does not mean everyone should stop abruptly.

The best approach depends on the original indication, current treatment schedule, risk of recurrent disease and the individual's preference and response.

Possible clinician-directed strategies include:

• Reducing an unnecessarily high dose
• Changing from twice-daily to once-daily treatment when appropriate
• Using an intermittent or on-demand regimen for selected uncomplicated reflux conditions
• Discontinuing treatment when there is no continuing indication
• Continuing maintenance therapy when there is a clear reason for it

These are treatment options, not a universal step-by-step withdrawal schedule.

People with severe erosive esophagitis, Barrett's esophagus, peptic strictures or substantial gastrointestinal bleeding risk may require ongoing treatment.

The goal is to use the treatment that provides appropriate protection with the least unnecessary medication burden.

Who Should Generally Not Stop PPIs Without a Specialist-Directed Plan?

Some medical conditions carry a higher risk of complications when acid suppression is withdrawn.

The American Gastroenterological Association advises particular caution about deprescribing in people with:

• A history of severe erosive esophagitis
• Esophageal ulcers or peptic strictures
• Known Barrett's esophagus
• Certain other established conditions requiring ongoing PPI treatment
• Substantial risk of upper gastrointestinal bleeding

People using PPIs to prevent ulcer-related bleeding while taking other medications also require an individualized risk assessment.

In these situations, maintaining acid suppression may provide important benefits.

Adding hydrochloric acid would not correct the underlying reason for protective therapy and could be inappropriate.

What if You Have Digestive Symptoms Despite Taking a PPI?

Persistent bloating, fullness, burping or discomfort while taking a PPI does not automatically mean that the medication has created a clinically important stomach-acid deficiency.

Although PPIs reduce acidity, digestive symptoms can have many different causes.

For example, symptoms may involve:

• Ongoing gastroesophageal reflux
• Weakly acidic reflux
• Reflux hypersensitivity
• Functional heartburn
• Functional dyspepsia
• Food intolerances
• Constipation
• Delayed gastric emptying
• Medication-related digestive effects

These conditions do not all respond to the same treatment.

A person with lactose intolerance may benefit from identifying lactose as a trigger, while someone with persistent reflux may require a review of GERD treatment.

Someone with constipation may need attention to bowel regularity rather than stomach-acid supplementation.

The best approach is to determine whether symptoms represent ongoing reflux, an overlapping digestive condition or another problem that has not yet been identified.

Does PPI Use Mean You Have Hypochlorhydria?

PPIs intentionally reduce gastric acid secretion, so they can produce a low-acid stomach environment during treatment.

However, medication-induced acid suppression is not necessarily the same as permanent loss of the stomach's ability to produce acid.

For example, someone taking omeprazole may have substantially reduced gastric acidity because the medicine is inhibiting proton pump activity.

That does not establish that the person's parietal cells are permanently damaged.

Other conditions, including atrophic gastritis and autoimmune gastritis, can impair acid secretion through changes in the stomach lining.

These differences matter because the appropriate response depends on the underlying mechanism.

Simply identifying reduced acidity during PPI treatment is not a reason to add hydrochloric acid.

Can Acid-Suppressing Medicines Affect Nutrient Absorption?

Yes. Reducing stomach acidity can influence certain processes involved in making nutrients available from food.

However, this does not mean everyone taking a PPI will develop nutritional deficiencies.

Vitamin B12

Stomach acid and gastric enzymes help release vitamin B12 from proteins in food.

Long-term acid suppression may reduce the release of food-bound vitamin B12 in some individuals.

However, vitamin B12 status also depends on dietary intake, intrinsic factor production, intestinal health and other factors.

Unexplained deficiency may justify evaluation, but routine B12 supplementation is not automatically required for every PPI user.

Iron

Gastric acidity supports the availability of certain forms of nonheme iron.

Prolonged acid suppression may affect iron absorption in susceptible individuals.

However, iron deficiency has many possible causes, including gastrointestinal blood loss.

Unexplained iron-deficiency anemia should not be attributed solely to medication without appropriate investigation.

Magnesium

Long-term PPI use has been associated with uncommon cases of clinically significant low magnesium.

Monitoring may be appropriate for selected individuals, particularly when other medications or medical conditions increase the risk of electrolyte disturbances.

Should You Take HCl to Prevent Nutritional Deficiencies?

No established clinical evidence supports routinely adding betaine HCl to PPI therapy to prevent vitamin or mineral deficiencies.

If a nutrient deficiency is identified, the priority is to determine its cause and provide appropriate treatment.

For example, vitamin B12 in fortified foods and supplements is generally present in a form that does not require the same release from food proteins.

Someone with intrinsic factor deficiency may require a specific B12 treatment strategy.

Correcting an identified nutritional problem is more reliable than assuming that adding stomach acid will solve it.

What Does Research Actually Show About Betaine HCl?

Betaine hydrochloride can temporarily increase gastric acidity under certain conditions.

In a small pilot study, researchers evaluated betaine HCl in six healthy volunteers whose gastric acid secretion had been suppressed experimentally using rabeprazole, a proton pump inhibitor.

After betaine HCl administration, gastric pH decreased rapidly, demonstrating temporary re-acidification.

The study showed that supplemental hydrochloric acid can produce a measurable change in the stomach's acidic environment.

However, several limitations are important.

The participants were healthy volunteers, not patients being treated for chronic GERD, ulcers or established digestive disorders.

The study primarily investigated gastric pH and the potential implications for the absorption of medications whose solubility depends on acidity.

It did not establish that betaine HCl improves reflux, restores normal digestive function in patients with atrophic gastritis or prevents nutritional deficiencies.

Nor did it demonstrate that routine supplementation is safe for people with active gastrointestinal inflammation.

A proven ability to temporarily lower gastric pH should not be confused with proven effectiveness as a treatment for digestive disease.

Who Should Avoid Self-Directed Betaine HCl Supplementation?

Hydrochloric-acid supplementation deserves particular caution when the gastrointestinal lining may already be injured or vulnerable.

People should not experiment with betaine HCl without appropriate professional assessment if they have:

• Active or suspected peptic ulcers
• Significant gastritis or stomach irritation
• Erosive esophagitis
• Persistent or severe GERD
• Gastrointestinal bleeding or symptoms suggestive of bleeding
• Unexplained persistent upper abdominal pain
• Prescribed acid-suppressing treatment for a condition requiring protection from acid

The use of nonsteroidal anti-inflammatory drugs, such as ibuprofen or naproxen, may also increase the importance of reviewing ulcer risk before considering acid supplementation.

These medicines can damage the protective gastrointestinal lining in susceptible individuals.

Betaine HCl does not treat these underlying risks.

People should also avoid using burning sensations as a method for adjusting their HCl dosage.

The commonly promoted practice of increasing HCl until discomfort develops is not a validated method for diagnosing low stomach acid or determining supplement requirements.

Should You Try HCl if You Believe Your Reflux Is Caused by Low Stomach Acid?

Reflux symptoms alone do not establish low stomach acid, and betaine HCl is not an established treatment for GERD.

Reflux primarily concerns the movement of stomach contents into the esophagus.

Gastric acid production and the prevention of reflux are related but distinct physiological functions.

A person can have low stomach acid and reflux at the same time.

However, the coexistence of those conditions does not prove that inadequate acid production caused the reflux.

Increasing gastric acidity does not automatically correct a weakened lower esophageal sphincter, hiatal hernia or other mechanical contributors.

In someone with esophageal inflammation, additional acid exposure may be inappropriate.

The useful approach is to identify the cause of persistent reflux rather than automatically assuming that restoring acidity will resolve it.

How Should You Approach a Medication Review Before Considering HCl?

If you want to reconsider acid-suppressing treatment or discuss hydrochloric-acid supplementation, a structured review can help clarify the next steps.

Step 1: Confirm Why the Medication Was Prescribed

Was the medicine started for occasional heartburn, documented GERD, erosive esophagitis, an ulcer or prevention of gastrointestinal bleeding?

The original diagnosis strongly influences whether discontinuation is appropriate.

Step 2: Review the Current Medication and Treatment Duration

Bring the medication name, dose, frequency and treatment history to the appointment.

Include prescribed medicines, over-the-counter acid reducers and relevant supplements.

This helps identify whether the treatment remains appropriate and whether medication effects could contribute to current symptoms.

Step 3: Describe the Digestive Symptoms That Remain

Explain whether you experience heartburn, regurgitation, bloating, excessive fullness, constipation, nausea or poor tolerance of particular foods.

These symptoms may arise from different mechanisms.

Understanding the pattern can help determine whether further investigation is warranted.

Step 4: Discuss Whether Additional Testing Is Needed

Depending on the circumstances, a healthcare professional may consider testing for H. pylori, evaluating unexplained nutritional deficiencies or investigating persistent reflux.

Upper endoscopy or reflux monitoring may be appropriate in selected situations.

Testing should be chosen according to the medical question being investigated.

Step 5: Determine Whether Deprescribing Is Appropriate

If there is no continuing indication for long-term acid suppression, the clinician may recommend discontinuation, dose reduction or another treatment schedule.

If a protective indication remains, continuing therapy may be the safer choice.

Step 6: Plan for Possible Rebound Symptoms

When discontinuation is appropriate, discuss what symptoms may occur and how they should be managed.

Rebound symptoms do not necessarily mean that lifelong treatment is required, but persistent symptoms may indicate recurrent disease.

Step 7: Reassess Before Adding HCl

Once the indication for acid suppression has been clarified, the clinician can evaluate whether there is a separate reason to investigate reduced gastric acidity.

HCl supplementation should not be treated as the automatic next step after stopping a PPI.

What Natural Digestive Strategies Can Help Without Stopping Prescribed Medication?

Several supportive habits may improve digestive comfort without interfering with prescribed acid suppression.

Eat at a Comfortable Pace

Chewing thoroughly and allowing adequate time for meals helps prepare food for digestion.

These habits do not directly increase stomach acid, but they support normal mechanical digestion.

Avoid Habitual Overeating

Unusually large meals may contribute to fullness or reflux in susceptible individuals.

Appropriate meal sizes can reduce digestive discomfort without requiring unnecessary food restriction.

Consider Meal Timing

For nighttime reflux, avoiding substantial meals within approximately two to three hours of bedtime may help reduce symptoms.

Identify Consistent Food Triggers

Some people experience reflux after particular foods or beverages.

Triggers vary, so it is generally better to identify foods that repeatedly worsen symptoms rather than eliminate every commonly blamed item.

Support Comfortable Bowel Function

Fiber, adequate fluid intake, movement and appropriate bowel habits can support regular elimination.

Constipation may contribute to bloating and abdominal discomfort that overlap with upper digestive symptoms.

Maintain Balanced Nutrition

Quality protein, appropriate dietary fiber, vegetables, fruits and healthy fats provide nutritional support.

People with documented deficiencies should address those needs according to the underlying cause.

Review Persistent Symptoms

If symptoms continue despite appropriate treatment and sensible lifestyle measures, investigate whether another digestive condition is present.

Adding more acid, enzymes or supplements without understanding the cause may delay more effective care.

Where Do Premier HCL and HCL Activator Fit?

Within the Total Health Secrets digestive-health program, Premier HCL is positioned as a supplemental hydrochloric-acid product, while HCL Activator is included as a companion product within selected stomach-acid support protocols.

These products have a specific intended role within the broader digestive-support framework.

They are not general substitutes for PPIs, H2 blockers or other prescribed treatment.

They also should not be presented as routine solutions for reflux symptoms or assumed nutritional deficiencies.

If a person is using acid-suppressing medication, the first priority is to understand why the treatment was prescribed and whether additional acid would be appropriate.

Other digestive-support categories may address different needs, such as digestive enzymes for selected food-breakdown concerns, fiber for certain bowel-regularity problems or probiotics for specific microbiome-related applications.

However, these products should also be selected for a clear purpose rather than automatically combined.

A well-designed digestive-support strategy matches the intervention to the actual digestive need while respecting necessary medical treatment.

Questions to Ask Your Healthcare Practitioner Before Changing Acid-Suppressing Medication

A medication review is more productive when the discussion is focused on the reason for treatment and what you hope to improve.

Useful questions include:

• What condition was this acid-suppressing medicine prescribed to treat?
• Do I still have a medical reason to continue it?
• Would reducing the dose or changing the treatment schedule be appropriate?
• Am I at risk of complications if I discontinue acid suppression?
• Could rebound acid symptoms occur, and how should they be managed?
• Could another digestive condition explain my continuing symptoms?
• Do I have risk factors that justify checking vitamin B12, iron or magnesium?
• Is there a valid reason to investigate reduced gastric acid production?
• Would supplemental hydrochloric acid be inappropriate given my medical history?

The answers can help establish a safer and more individualized plan.

When Should You Seek Prompt Medical Attention?

Digestive symptoms should not always be managed through medication adjustments or supplement experiments.

Medical evaluation is important when symptoms include:

• Persistent or worsening upper abdominal pain
• Difficulty swallowing or painful swallowing
• Food becoming stuck in the esophagus
• Persistent vomiting
• Unexplained weight loss
• Unexplained anemia
• Significant loss of appetite
• Reflux symptoms that continue despite appropriate treatment

Vomiting blood, passing black tarry stool or experiencing severe abdominal pain may indicate a serious gastrointestinal problem and requires urgent assessment.

New or unexplained chest pain, especially with shortness of breath, sweating, faintness or pain radiating into the arm or jaw, also requires urgent medical evaluation.

These symptoms should not be assumed to result from simple indigestion or low stomach acid.

The Bottom Line: Do Not Stop Acid Suppression Just to Try HCl

Stomach acid is a necessary part of normal digestion.

It helps activate pepsin, begins the breakdown of dietary proteins, contributes to nutrient availability and supports the stomach's barrier against many swallowed microorganisms.

However, the importance of stomach acid does not mean that everyone taking an acid-suppressing medicine should stop treatment or begin hydrochloric-acid supplementation.

PPIs and H2 blockers can be important for controlling reflux-related injury, healing ulcers and protecting people at risk of gastrointestinal complications.

Some people may be able to reduce or discontinue PPI treatment when the original indication no longer exists.

Others require ongoing therapy because stopping treatment would create an unacceptable risk of recurrent disease or tissue injury.

Rebound acid symptoms may also occur after discontinuing prolonged PPI treatment, and persistent symptoms require consideration of whether the underlying condition remains active.

Betaine HCl can temporarily increase gastric acidity, but that physiological effect has not established it as a replacement for acid-suppressing medicines or a proven treatment for GERD.

The safest and most useful approach is to clarify why acid suppression is being used, determine whether it remains necessary and consider stomach-acid support only when there is an appropriate, individually assessed reason.

The goal of digestive care is not to suppress stomach acid indefinitely without a reason, nor to increase it simply because it is physiologically important.

It is to maintain normal digestive function while protecting the tissues and systems that may be vulnerable to injury.

For a broader explanation of stomach acid, digestive enzymes, nutrient absorption, gut bacteria and elimination, continue reading our pillar guide: Digestive Health Explained: Stomach Acid, Enzymes, Gut Bacteria, Absorption and Elimination.

References and Further Reading

1. American Gastroenterological Association. De-prescribing Proton Pump Inhibitors (PPIs). 2022. Clinical best-practice advice on reviewing PPI indications, deprescribing, rebound symptoms and situations requiring continued treatment.
2. Targownik LE, Fisher DA, Saini SD. AGA Clinical Practice Update on De-Prescribing of Proton Pump Inhibitors: Expert Review. Gastroenterology. 2022. Explains when deprescribing may be appropriate and why decisions should be based on clinical indications.
3. Katz PO, Dunbar KB, Schnoll-Sussman FH, et al. ACG Clinical Guideline: Diagnosis and Management of Gastroesophageal Reflux Disease. American Journal of Gastroenterology. 2022;117:27-56. Evidence-based recommendations on PPI treatment, maintenance therapy, reflux management and lifestyle interventions.
4. American Gastroenterological Association. Personalized Approach to the Evaluation and Management of GERD. 2022. Discusses individualized treatment, diagnostic evaluation and medication management.
5. Yago MR, et al. Gastric Re-acidification With Betaine HCl in Healthy Volunteers With Rabeprazole-Induced Hypochlorhydria. 2013. Pilot research demonstrating temporary changes in gastric pH following betaine HCl administration under experimental conditions.
6. U.S. Food and Drug Administration. Over-the-Counter Heartburn Treatment. Explains OTC antacids, H2 blockers, PPIs and appropriate short-term use.
7. National Institutes of Health, Office of Dietary Supplements. Vitamin B12: Health Professional Fact Sheet. Discusses food-bound vitamin B12 absorption and the influence of gastric acid suppression.
8. National Institutes of Health, Office of Dietary Supplements. Iron: Health Professional Fact Sheet. Reviews nonheme iron absorption and relevant nutritional considerations.
9. National Institute of Diabetes and Digestive and Kidney Diseases. Treatment for GER and GERD. Describes established reflux treatments and the role of acid-suppressing medications.

Educational Disclaimer: This article provides general educational information and is not a substitute for individualized medical advice, diagnosis or treatment. Acid-suppressing medicines may be necessary to heal or prevent serious gastrointestinal injury. Do not stop, reduce or replace prescribed treatment with betaine HCl or other supplements without appropriate guidance from a qualified healthcare professional. Persistent or concerning digestive symptoms require medical evaluation.